Skip to main content

Table 1 Clinicopathologic characteristics of 84 unresectable stage III non-small-cell lung cancer patients

From: FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy

Characteristic

Patients

Age (y)

 

Median, year (range)

70 (37–87)

Gender

 

Male

55 (65.5%)

Female

29 (34.5%)

KPS

 

Median (range)

90 (70–100)

Smoking history

 

Yes

77 (91.7%)

No

7 (8.3%)

Histology

 

Squamous

38 (45.2%)

Adenocarcinoma

34 (40.5%)

NSC NOS

12 (14.3%)

GTV

 

Median, cm3 (range)

96.6 (4.1-753.2)

SUV1

 

Median value (range)

14.2 (2.5-66)

Median time, month (range)

0.7 (0.1-2.7)

SUV2

 

Median value (range)

3.6 (1.9-28.1)

Median time, month (range)

4.2 (0.8-6.0)

  1. Abbreviations: KPS = Karnofsky Performance Status; NSC NOS = non-small cell cancer and no otherwise specified; GTV = gross tumor volume; SUV = standardized uptake values.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us